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ABSTRACT
Objective: To identify the features and effects of a
pathway for emergency assessment and referral of
patients with suspected transient ischaemic attack
(TIA) in order to avoid admission to hospital.
Design: Scoping review.
Data sources: PubMed, CINAHL Web of Science,
Scopus.
Study selection: Reports of primary research on
referral of patients with suspected TIA directly to
specialist outpatient services.
Data extraction: We screened studies for eligibility
and extracted data from relevant studies. Data were
analysed to describe setting, assessment and referral
processes, treatment, implementation and outcomes.
Results: 8 international studies were identified, mostly
cohort designs. 4 pathways were used by family
doctors and 3 pathways by emergency department
physicians. No pathways used by paramedics were
found. Referrals were made to specialist clinic either
directly or via a 24-hour helpline. Practitioners
identified TIA symptoms and risk of further events
using a checklist including the ABCD2 tool or clinical
assessment. Antiplatelet medication was often given,
usually aspirin unless contraindicated. Some patients
underwent tests before referral and discharge. 5
studies reported reduced incident of stroke at 90 days,
from 6–10% predicted rate to 1.3–2.1% actual rate.
Between 44% and 83% of suspected TIA cases in
these studies were referred through the pathways.
Conclusions: Research literature has focused on
assessment and referral by family doctors and ED
physicians to reduce hospitalisation of patients with
TIA. No pathways for paramedical use were reported.
We will use results of this scoping review to inform
development of a paramedical referral pathway to be
tested in a feasibility trial.
Trial registration number: ISRCTN85516498.
Stage: pre-results.
INTRODUCTION
Transient ischaemic attack (TIA) is a neuro-
logical event characterised by the resolution
of focal and non-focal symptoms within
24 hours and with limited associated seque-
lae.1 Clinical studies have demonstrated that
patients who have a TIA are at risk of further
TIAs, stroke and death.2–5 Delays in the pro-
cesses of care for TIA have consequences for
the health and satisfaction of patients.
Inefﬁciencies in provision of care may
increase the burden on health services, par-
ticularly emergency and secondary care.6 In
the UK, stroke has a direct cost to the
National Health Service (NHS) of £2.8 billion
Strengths and limitations of this study
▪ This is the first attempt to systematically search
and describe referral pathways for patients with
transient ischaemic attack (TIA) to gain timely
access to appropriate specialist assessment,
thereby avoiding hospital admission.
▪ We followed a systematic approach based on
guidance for carrying out a scoping review and
reported our methods fully: that our research
team included paramedics, ambulance service
managers, nurses, stroke clinicians and patients
alongside experienced trialists, provided a broad
and complementary range of perspectives to
implement our review and interpret findings.
▪ We balanced resources and timescales against
need to inform intervention development in our
feasibility study; we discussed methods and find-
ings within the study team to assess and
monitor processes.
▪ We did not assess the reporting quality of
papers. However, all were published in inter-
national peer-reviewed journals and we have
reported study results to aid interpretation, in
line with recommendations.
▪ Our findings, which suggest there is potential for
paramedics who are often the first healthcare
professionals to attend, assess and refer sus-
pected TIA cases, will be used to inform devel-
opment of an intervention for paramedics to be
tested in a feasibility trial.
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per year; informal care costs of £2.4 billion per year and
costs the economy £1.8 billion per year.7
TIAs are not always regarded as emergencies since the
stroke-like symptoms present and resolve in a short time
without treatment. Symptoms may therefore be ignored
or disregarded by patients, their families and even by
ﬁrst contact clinicians.5 8–10 Risk of stroke following a
TIA can be assessed using the ABCD2 tool which consid-
ers age, blood pressure, clinical features of TIA, duration
and presence of diabetes in a 0–7 scoring system.11
Patients with low-risk TIA are diagnosed as having an
ABCD2 score of 0–3 which is associated with a 1% risk
of stroke within the following 2 days. Higher ABCD2
scores (4–5 or 6–7) are associated with greater risk of
stroke during the following 2, 7, 30 and 90 days after a
TIA.11 In the UK, the National Institute for Health and
Care Excellence (NICE) recommends that low-risk
patients with TIA are assessed by a specialist within
1 week, and that high-risk patients with TIA are assessed
by a specialist within 24 hours.12 Many patients present
with suspected TIA to the emergency ambulance service
and then encounter delays in hospital before being seen
by a stroke or TIA specialist.13
Treatment of TIA has been identiﬁed as one of the
conditions potentially able to receive an alternative
response to traditional conveyance by ambulance to hos-
pital.14 Low-risk patients with TIA can be managed safely
and effectively as outpatients, without hospital-based
treatment.15 16 However, risk of hospitalisation for a
patient with TIA increases with emergency department
(ED) overcrowding, suggesting clinicians’ decision-
making is affected by the pressured environment.17 As
the role of ambulance services in the UK and inter-
nationally has shifted, from predominantly assessment
and transport to hospital to clinical assessment and
decision-making on scene, ambulance services are
exploring alternative care pathways for appropriate
low-risk patients, to refer direct to relevant specialist ser-
vices (eg, mental health services, diabetes specialist) or
leave patients at home.18–27 Increased demand for emer-
gency and prehospital care has been highlighted by the
media on numerous occasions.28–30 Paramedics routinely
identify and assess patients who suffered stroke before
transporting direct to stroke centres.14 Some ambulance
services are now setting up alternative pathways for pre-
sumed low-risk suspected TIA with protocols for direct
referral to specialist services, avoiding the ED. Recent
guidelines recommend paramedics use a validated tool
to identify patients’ risk of further TIA or stroke and
safely refer to specialist TIA services.14 31 However, the
ABCD2 tool has not yet been validated in a prehospital
context and the evidence is inconclusive about how best
to assess risk in this patient group and safely make refer-
rals along appropriate clinical pathways,31–34 new knowl-
edge about safety, effectiveness and costs of this new
model of care is therefore limited.14 35
The Welsh Ambulance Service NHS Trust and PRIME
Centre Wales received funding to assess the feasibility of
assessment and referral of patients with low-risk TIA by
paramedics directly to TIA clinic rather than conveyance
to the ED. The TIER (Transient Ischaemic Attack 999
Emergency Referral) study is designed to test whether
this intervention is acceptable and whether study design,
recruitment and data collection are achievable in order
to plan a fully powered randomised trial if preset pro-
gression criteria are met.36 Our protocol is available
from the authors. We have obtained ethical approval
and begun recruitment. Potential beneﬁts of the new
pathway include timely specialist review for patients
with low acuity TIA without: adverse consequences; the
inconvenience of ED attendance; and unnecessary cost
to the NHS.
To inform development of an ambulance paramedic
referral for TIA, we conducted a scoping review of the
literature to identify existing prehospital emergency
pathways and evidence about their implementation and
effectiveness. Scoping reviews are suitable for undertak-
ing rapid mapping of the literature in areas where little
previous investigation has been undertaken37 38 and
can inform further research and practice.37–45 They are
concerned with ‘contextualizing knowledge…and
then setting this within policy and practice contexts’
(p. 10).39
The objective of this review is to identify the features
and effects of a pathway for emergency assessment and
referral of patients with suspected TIA in order to avoid
admission to hospital and gain timely access to appropri-
ate outpatient-based specialist assessment.
METHODS
We followed guidance for undertaking a rapid scoping
review,38 46 while noting that speciﬁc advice for scoping
reviews is not available45 (see also http://www.
equator-network.org/).
Eligibility criteria
We included studies reporting descriptive and effective-
ness data about assessment and referral pathways for
patients with TIA directly referred to specialist services,
avoiding hospital admission. We excluded studies where
patients were admitted to a designated observation unit
or stroke centre or who were treated in the ED without
receiving an outpatient referral because these treatment
routes did not incorporate referral to avoid admission
to a secondary care centre. We also excluded studies
which did not report enough information to allow us to
replicate the pathway. In line with advice to search
widely across the literature,37 41 we sought any study
method. Our inclusion and exclusion criteria are shown
in table 1.
Information sources and search strategy
We searched four electronic databases (PubMed,
CINAHL, Web of Science and Scopus). We tested and
revised our search strategy to focus on TIAs and the
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prehospital setting after initial searches, which included
the terms ‘mini-stroke’, ‘stroke’, ‘pathway’, ‘care’ and
‘treatment’ identiﬁed the literature on stroke treatment,
care pathways and guidelines rather than TIAs.38 Our
research team discussed results of early scoping searches
allowing us to clarify the features of a referral pathway
(eg, from any community or prehospital route) and
patient group (eg, patients no longer displaying TIA
symptoms).44 47 In this way, we combined a broad ques-
tion with a clearly articulated scope of enquiry.40 Our
ﬁnal search strategy included the following search terms:
(TIA OR Transient Ischaemic Attack OR Transient
ischemic attack) AND (999 OR prehospital OR pre-
hospital OR ambulance OR ambulances OR ambu-
lance* OR paramedic* OR emergency).
We used MeSH headings and key words where pos-
sible. We carried out our searches in January and
February, 2016. We limited searches to English language
reports published between 2005 and 2015.
Study selection
Two authors (BAE and MJ) undertook a two-stage
screening process against inclusion criteria for selection
of studies identiﬁed through electronic searches: (1)
screening by title and abstract to identify potentially eli-
gible studies; and (2) assessing full papers to conﬁrm
those suitable for inclusion in this review. Differences
were resolved in discussion, with a third reviewer (ACS)
available to mediate if required.
Data extraction, presentation and reporting
We extracted data on a predeﬁned table. We adapted
this from the Cochrane Collaboration Handbook48 to
ensure our review approach retained systematic and
clear standards of reporting. We presented results
according to PRISMA guidance49 using a ﬂow chart,
table and narrative summaries to chart key items of
information.50 Data extraction was undertaken by BAE
and JB.
Quality assessment
We did not assess the quality of evidence reported by
papers included in our scoping review. Arksey and
O’Malley38 state that scoping reviews should not present
the ‘weight’ (p. 18) of evidence, which they deﬁne as
robustness or generalisability, by assessing the quality of
reporting by included papers. However, we sought to
clearly report study ﬁndings so that the reader can deter-
mine potential bias in this paper’s ﬁndings and
discussion.38
RESULTS
Characteristics
Of the 2374 references reviewed, 31 full papers were
obtained and 9 papers reporting 8 studies met our
inclusion criteria (see ﬁgure 1). Characteristics of
included studies are reported in table 2. Two papers
each reported studies undertaken in the UK,6 51
France52 53 and Australia54 55 and one in Canada.56 Two
papers reported the protocol57 and results58 of a study
undertaken in New Zealand. One randomised con-
trolled trial was identiﬁed;58 other studies incorporated
a control group, either using a before and after6 51 53 or
cohort design.53 55 57 Two papers56 57 presented a study
with no results included. Number of patients ranged
from 185 to 1085. Data collection periods ranged from 3
to 36 months. All papers were published in international
peer-reviewed journals reporting general medical, stroke
or neurological studies.
Referral and treatment pathway
Three studies described a referral pathway initiated in
the ED by physicians when presented with a patient with
suspected TIA.53–55 Patients were assessed against
Table 1 Inclusion and exclusion criteria for studies included in the scoping review
Inclusion criteria Exclusion criteria
Population Patients presenting with suspected TIA Patients presenting with ongoing symptoms
suggestive of stroke
Patients presenting with recurrent or crescendo
focal neurological symptoms
Intervention Assessment, referral and treatment for suspected TIA in
order to avoid admission to hospital
Intervention described in enough detail to be replicable
Attendance at ED as part of a referral pathway to avoid
hospital admission
Admission to hospital
Admission to a designated observation ward or
unit
ED treatment without a referral pathway
Lack of information about assessment, treatment
or referral criteria and processes
Comparator Any study design: no comparator necessary
Outcomes Outcomes not necessary
Study design Any study design
English language
Published 2005–2015
Editorial, opinion and discussion pieces
ED, emergency department; TIA, transient ischaemic attack.
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predeﬁned criteria,54 a checklist55 or algorithm52 and
then referred to a specialist clinic instead of being
admitted for evaluation at the ED. Appointment
arrangements varied between referral models. In the
Monash TIA Triaging Treatment (M3T) pathway,54 a
stroke registrar and nurse triaged new referrals and
made appointments according to priority. Appointments
reﬂected clinical need in the Grifﬁths et al55 study
also and could be provided the same day if clinically
required54 55 or within 4–6 weeks if antiplatelet treat-
ment had been initiated.54 However, Montassier et al53
reported that appointments were made for 8–15 days
after referral. In the Grifﬁths et al55 study, patients
received an education pack with instructions to follow-up
with the general practitioner and call an ambulance if
symptoms recurred.
The ﬁve other studies described a referral pathway
which was initiated by the family doctor when a patient
presented to them. In three studies, the doctor used a
checklist (ABCD2 or one provided for the study) to
identify patients with suspected low-risk TIA. The doctor
then called a consultant-led 24-hour telephone
hotline51 52 56 to gain specialist advice and referral to
stroke treatment service according to symptom severity
and urgency. The doctor was able to discuss symptoms
and severity with the specialist staff and agree whether
referral was required and how soon the patient should
be seen if an appointment was agreed to be neces-
sary.51 56 In the fourth study,6 the doctor directly
referred patients with suspected TIA to a daily specialist
clinic where no appointment was required. The clinic
then conﬁrmed the doctor’s diagnosis and arranged for
treatment to begin. Rothwell et al6 and Lavallée et al52
reported that clinic treatment reports and advice were
sent to the patient’s family doctor detailing blood tests,
brain scans and prescribed medication for hypertension
and anticoagulation to reduce risk of further TIAs.
Family practitioners were advised of the new referral ser-
vices through letters and leaﬂets which included infor-
mation about risks, diagnosis and management of stroke
and TIAs. Ranta et al57 described an online decision
support tool accessed by family doctors through a menu
button situated on the navigation bar of their practice
management software. This provided a single page of
tick boxes concerning relevant aspects of presenting
illness history and a brief focused physical examination.
The software automatically populated ﬁelds for relevant
medical history (such as diabetes and smoking) from
the practice management system. Using inputted data,
the software conﬁrmed or rejected TIA or stroke as the
likely diagnosis. If conﬁrmed, it generated a triage
option based on the ABCD2 score supplemented by vari-
ables from the New Zealand TIA guidelines. For low-risk
patients, general practitioners (GPs) were given two
Figure 1 Search results.
4 Evans BA, et al. BMJ Open 2017;7:e013443. doi:10.1136/bmjopen-2016-013443
Open Access
options. The ﬁrst was to refer to outpatient TIA clinic
using an automatically generated referral form. This
contained all the information needed by a specialist to
prioritise patients appropriately. Or the doctor could
chose to manage the patient in the community following
a step-by-step process covering prescriptions, radiology
referral and information forms to give to the patient.
Studies reported a wide range of criteria to include
and exclude patients (see table 3). Jeerakathil et al56 and
Grifﬁths et al55 used the ABCD2 scores to identify
patients with suspected low-risk TIA. The decision
support system described by Ranta et al57 used ABCD2
scores supplemented by other variables taken from the
New Zealand TIA guidelines. Kerr et al51 and Montassier
et al53 reported that doctors used an algorithm which
considered time since symptom onset, symptoms experi-
enced, extent of recovery and presence of atrial ﬁbrilla-
tion. ED physicians in the Sanders et al54 study applied
the International Classiﬁcation of Diseases (ICD)10
Australian Modiﬁcation TIA code G45.8 or G45.9 while
family doctors in the Lavallee et al52 study made their
assessments based on clinical expertise. Rothwell et al6
did not specify how family doctors assessed TIA.
Common features of pathways included the following:
▸ Suspected TIA diagnosis and risk assessment were
made using a symptom-based algorithm or the
ABCD2 score;
▸ Low-risk patients with suspected TIA, suitable for the
referral pathway, had an ABCD2 score <4 (where
stated);
▸ Patients could be referred to clinic without appoint-
ment, via a central contact point or electronic system
which led to arrangements for attendance during the
next 2 weeks;
▸ Antiplatelet therapy, generally aspirin unless contrain-
dicated, was prescribed before discharge;
▸ Patients received comprehensive tests and further
treatment at outpatient clinic (such as blood tests,
brain scans, medication for hypertension and
anticoagulation).
Further details about the referral and treatment path-
ways are provided in table 3.
Table 2 Characteristics of included studies
Reference Country Method Sample size
Period of data
collection
Sanders
et al54
Victoria, Australia Prospective before and after
study
Before intervention: 169
patients
After intervention: 301
confirmed TIA cases
Before: 12 months
(2003–2004)
After: 36 months
(2004–2007)
Montassier
et al53
Nantes, France Prospective cohort study 118 patients 12 months
January to
December 2009
Griffiths
et al55
New South Wales,
Australia
Prospective cohort study 200 patients 22 months
October 2008 to July
2010
Lavallee
et al52
Paris, France Prospective cohort study 1085 patients 24 months
January 2003 to
December 2005
Rothwell
et al6
Oxfordshire,
England
Prospective before and after
study nested within a
population-based incidence
study of all TIA and stroke
(OXVASC study)
644 patients presented with
TIA or stroke
281 referred for outpatient
assessment using EXPRESS
treatment protocol
30 months
1 October 2004 to
31 March 2007
Kerr et al51 Lothian, Scotland Audit of telephone hotline and
referral within prospective before
and after study of reconfigured
stroke service
376 calls to hotline 3 months
Jeerakathil
et al56
Alberta, Canada Algorithm and hotline pathway
developed through consensus
process. Reported in protocol
for before and after study
Study protocol 15-month
implementation
period
Ranta et al57
Ranta et al58
New Zealand Cluster randomised controlled
trial
Study protocol57
Results58
56 general practices (29
intervention)
172 intervention group patients
119 intervention group patients
13.5 months
24 February 2012 to
15 May 2013
TIA, transient ischaemic attack.
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Table 3 Referral and treatment pathways for patients with suspected TIA
Study
Setting and
intervention
Assessment and
recognition of TIA
Criteria for referral pathway
(inclusion/exclusion
criteria) Referral process Management or treatment
Sanders
et al54
ED
Triage based on clinical
expertise in consultation
with stroke team; referral
to stroke clinic (priority or
4–6 weeks)
ED physician assesses
patient for TIA. Diagnosis
confirmed by stroke
neurologist after clinical
consultation.
All patients were assigned
ICD10 Australian
Modification TIA code
G45.8 or G45.9.
Definition of TIA for diagnosis
into M3T pathway: ‘acute loss
of focal cerebral or monocular
function with symptoms
lasting <24 hours and thought
to be due to inadequate
cerebral or ocular blood
supply as a result of arterial
thrombosis or embolism’.
ED physician faxes
standardised TIA referral to
daily TIA clinic to facilitate
outpatient review. Stroke
registrar and nurse triage
referrals daily with priority
appointments for ipsilateral
internal carotid artery
stenosis ≥50%; confirmed
symptomatic stenosis ≥70%;
AF. Other patients seen
within 4–6 weeks if
antiplatelet therapy is started
in ED.
M3T treatment pathway:
1. Emergency physician evaluation
of patient in consultation with
stroke team
2. Urgent CT brain imaging, ECG
and baseline blood tests (forms
marked TIA pathway to
expedite)
3. Antiplatelet therapy/warfarin/
antihypertensive therapies/
lipid-lowering therapies
(depending on test results)
Montassier
et al53
ED
Triage based on decision
algorithm; referral to
stroke clinic (8–15 days)
ED physician uses
decision algorithm: yes/no
answers
Total recovery of
symptoms
Normal physical
examination Normal blood
tests results (white cell
counts and platelet counts,
red blood cells, glucose,
ionogram and creatinine)
ECG negative for AF
Cranial CT negative for
bleeding or other diagnosis
All yes=discharge to
outpatient TIA evaluation
One no=admit patient
All discharged patients were
managed as outpatients in
8–15 days
Antiplatelet therapy started
before discharge.
At outpatient clinic (8–15 days later),
all received extracranial Doppler
testing of supra aortic arteries and
vascular neurology consultation
Griffiths
et al55
ED
Triage based on ABCD2
checklist; referral for
neurological review and
stroke clinic (timings
based on risk
stratification)
ED physician uses ABCD2
checklist to identify TIA
and risk status
Exclusion:
ABCD2 scores ≥4 or high-risk
features (neurologist
contacted)
Inclusion:
score <4 and no high-risk
features (including known
carotid disease, AF,
crescendo TIA)
Fax request by departmental
secretary for expedited
neurologist review.
Refer patients to outpatient
CT angiography or carotid
ultrasound and request
echocardiogram and Holter
monitor scan to exclude
patients with haemorrhage
Initiate antiplatelet therapy if
not already on warfarin
After neurologist review, patients
with ABCD2 scores ≥4 could be
discharged. Patients provided with
patient education pack with
instructions:
How to start aspirin and aspirin/
dipyridamole
Follow-up with GP within 7 days
Call ambulance if symptoms recur.
Departmental secretary contacts
patient and arranges follow-up with
neurologist.
Continued
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Table 3 Continued
Study
Setting and
intervention
Assessment and
recognition of TIA
Criteria for referral pathway
(inclusion/exclusion
criteria) Referral process Management or treatment
Lavallée
et al52
Primary care
Triage based on clinical
expertise with access to
24-hour consultant-led
hotline and outpatient
stroke clinic
Family doctor identifies
TIA
Focal symptoms of brain or
retinal dysfunction
Sudden onset and presumed
to be related to ischaemia
Patients had subsequently
made total recovery
Family doctor calls 24-hour
hotline if suspects TIA
Family doctor phone call
triaged as TIA by stroke
nurse (0900–1700) or senior
vascular neurologist (1700–
0900)=patient attends clinic
1. Assessment within 4 hours of
admissionClinical assessment
by vascular neurologist
2. Tests: MRI or CT brain imaging;
ultrasonography and transcranial
Doppler imaging;
electrocardiography; blood tests
for lipid profile, iconography, red
and white cell count and platelet
count, glucose, haemoglobin A,
C reactive protein, creatinine
3. Vascular neurologist discusses
case with referral doctor. Patient
identified for discharge (unless
admission criteria met)
4. Prevention therapy targets sent
to family doctor (blood pressure,
LDL cholesterol, aspirin
administration, smoking status
and treatment started if possible)
5. Antithrombotic treatment started
6. Patients given anticoagulant,
antiplatelet or carotid
revascularisation as appropriate
7. Discharge
Rothwell
et al6
Primary care
Direct GP referral to daily
TIA clinic
GP identifies suspected
TIA. No details provided of
assessment or recognition
process.
No details provided GP directly refers patients
with suspected TIA to daily
afternoon TIA/minor stroke
clinic (no appointment
necessary)
Stroke clinic confirms diagnosis and
begin treatment:
Aspirin or clopidogrel
Simvastatin
Blood pressure lowering
Anticoagulation
4-week prescription provided for all
medication
CT brain scan obtained for patients
with incomplete resolution of
symptoms at time of assessment
Report of assessment,
investigations and treatment faxed
to GP within 24 hours
Continued
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Table 3 Continued
Study
Setting and
intervention
Assessment and
recognition of TIA
Criteria for referral pathway
(inclusion/exclusion
criteria) Referral process Management or treatment
Kerr et al51 Primary care
Triaging algorithm with
access to 24-hour
consultant-led hotline
and outpatient stroke
clinic (additional
appointment slots
created for pathway)
Algorithm provided to GPs:
1. Does patient have focal
neurological deficits?
2. Are symptoms still
present?
3. Did symptoms come on
rapidly?
4. Did symptoms start
within past 4 hours?
5. Did symptoms start
while patient was
awake?
Answers to five algorithm
questions:All yes, ring 999:
may need thrombolysis
q2 yes, q4 or q5 no: discuss
with stroke consultant today:
ring bed bureau or hotline
q2 no: ring stroke line, patient
seen within 7 days
q1 no: unlikely TIA, refer to
another service
Options for GP/consultant in
discussion via telephone
helpline:
Appointment time for GP to
immediately give patient
Go to ED
Call 999
Refer patient to appropriate
service
Advice but agree no further
secondary assessment
needed
No details provided
Jeerakathil
et al56
Primary care
Triaging algorithm with
access to 24-hour
consultant-led hotline
and outpatient stroke
clinic
Triaging algorithm for
primary care physicians
when viewing patients with
suspected TIA or stroke to
assess risk—high, medium
or low
High-risk: (1) symptom onset
within past 48 hours with any
of the following—motor deficit
lasting more than 5 min;
speech deficit lasting more
than 5 min; ABCD2 score ≥4;
(2) atrial fibrillation with TIA.
Medium risk: (1) symptom
onset between 48 hours and
7 days with any of the
following—motor deficit
lasting more than 5 min;
speech deficit lasting more
than 5 min; ABCD2 score ≥4.
Low-risk: (1) symptom onset
≥7 days; (2) symptom onset
≤7 days without the presence
of high-risk symptoms.
Unsure: physician contact 24
stroke hotline for immediate
access to stroke specialist
High-risk: physician contacts
24 hour hotline for immediate
access to stroke expert.
Patient assessed by stroke
specialist and has
investigations completed
within 24 hours.
Medium risk: patients are
seen promptly in nearest
stroke prevention clinic
(within 3 days)
Low-risk: patients seen soon
in nearest stroke prevention
clinic (within 2 weeks)
Unsure: based on advice of
stroke specialist
No details provided
Ranta
et al57
Primary care
Internet-based clinical
decision support tool
GP uses decision support
tool; single page of tick
boxes covering
Software confirms or rejects
TIA/stroke diagnosis based
on data entered by GP.
Software offers GP two
options:
1. Software generates referral form
for TIA outpatient clinic with
Continued
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Four studies52 51 56 57 described the training and
implementation processes provided to family doctors to
support TIA referral pathways. These involved informa-
tion leaﬂets about TIA and the referral pathways, dis-
tributed before and during the studies. Ranta et al57
provided GP training on TIA and stroke management.
Jeerakathil et al56 also reported that an education strat-
egy, for doctors and the general public, was under-
taken. Training and implementation processes are
described in table 4.
Processes and outcomes
Six studies51–55 58 reported stroke rates at 90 days,
varying from 1.2% (n=13)52 and (n=2)58 to 2.1%
(n=6).6 Montassier et al53 also reported that three TIAs
occurred, representing 5% of low-risk patients with TIA
referred to stroke clinic by emergency physicians. In
that study, the conﬁrmed stroke rate was 1.7% whereas
predicted stroke rates at 90 days (predicted using the
ABCD2 tool) was 9.7%. Lavallée et al52 identiﬁed the
predicted stroke rate of all presenting patients as 6%
compared with the actual ﬁgure of 1.2%. Four
studies6 52–54 reported that between 44% and 82.6% of
suspected low-risk patients with TIA were referred
through the pathways designed to avoid hospital admis-
sion. Ranta et al58 reported that 76% of patients
managed by GPs using the decision support tool
received management consistent with national guide-
lines compared with 41% of patients managed by GPs
who did not have access to the tool. Outcomes are
reported in table 5.
Kerr et al51 reported that delays in clinic assessment
and carotid surgery for patients with TIA reduced sig-
niﬁcantly (p<0.01) after the introduction of their
hotline—from 58 days before (range 6–135) to
21.5 days after (range 5–82). Two-thirds (67%: n=248)
of cases referred using their hotline were seen by a spe-
cialist within 24 hours; most cases (94%: n=347) were
seen by a specialist within 96 hours. Of the 88% of GPs
surveyed about the pathway, 94% were ‘very satisﬁed’
with the process; no specialist described any critical
incident because the hotline call disrupted their activ-
ity. No other studies reported these data.
Sanders et al54 and Rothwell et al6 reported the differ-
ence in stroke risk before and after the implementation
of their pathway (at 90 days). For patients with con-
ﬁrmed TIA, Sanders et al54 found a 3.78% (95% CI
−0.19% to 9.89%) reduction in stroke risk following
implementation of their pathway—from 5.84% before
(95% CI 3.1% to 10.73%) to 1.74% after (95% CI
0.88% to 3.39%). Rothwell et al6 provided an adjusted
HR for stroke risk following implementation of their
pathway of 0.20 (95% CI 0.8 to 0.49; p=0.0001). Stroke
risk was reportedly 10.3% before pathway implementa-
tion compared with 2.1% after (p=0.001).
Ranta et al58 reported economic analysis favouring
the use of electronic decision support by GPs to triage
patients with suspected TIA and stroke with a treatment
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cost ratio of 0.65 (95% CI 0.47 to 0.91, p=0.013). No
increased adverse events were recorded. Clinician feed-
back was positive.
Other results provided by the included studies may be
of use in developing our intervention. For example,
Grifﬁths et al55 reported that some included patients
were found to have a diagnosis other than TIA, includ-
ing migraine, presyncope, Bell’s palsy and seizure with
TIA-mimicking symptoms. Sanders et al54 reported that
there were no signiﬁcant differences in stroke outcome
between patients who were admitted (n2/N85; 2.35%)
and patients who were not admitted (n5/N4.3; 1.24%).
Lavalée et al52 found that 74% (n=808) of their included
patients did not require admission following examin-
ation at their 24-hour access clinic.
DISCUSSION
Summary of findings
We identiﬁed nine international papers reporting eight
studies which described pathways to refer patients with
suspected TIA for specialist evaluation. In all cases, pre-
hospital decisions about patient care were made by phy-
sicians. We identiﬁed ﬁve pathways which were delivered
in primary care, where family doctors identiﬁed and
referred patients with suspected TIA through an elec-
tronic decision support tool, a consultant-led telephone
service or directly to clinic. In three studies, ED physi-
cians assessed and referred suitable patients to prevent
hospital admission. Outcome data suggested that
numbers experiencing another stroke or TIA within
90 days were reduced in patients treated through these
Table 4 Referral pathway implementation processes
Study Setting Implementation process, including training and educational materials
Sanders et al54 ED No details reported
Montassier et al53 ED No details reported
Griffiths et al55 ED No details reported
Lavallee et al52 Primary care Leaflet on TIA emailed to family doctors, cardiologists, neurologists, ophthalmologists and
EDs with information on definition, key symptoms, risks, main causes and emergency
treatment of TIA emphasising opportunity to prevent potentially devastating stroke.
Leaflet also advised of TIA clinic and free hotline phone number.
Rothwell et al6 Primary care No details reported
Kerr et al51 Primary care All GPs in area were sent written guidelines and hotline telephone number by email and
post twice, 6 months apart
Reminder about service on footnote of every subsequent letter to GPs
Jeerakathil et al56 Primary care Pocket cards and PDF documents distributed province wide
Presentations given
Education modules about TIA management and slide sets created
TIA triaging algorithm adopted as TIA education strategy by province stroke strategy with
materials on website
Knowledge of protocol shared with staff involved in care of patients who suffered stroke;
communication with all stroke prevention clinics
Public education campaign about signs and symptoms of stroke
Ranta et al57
Ranta et al58
Primary care All study GPs were invited to an education session reviewing management of TIA and
stroke, also with a briefing about study processes. Posters were displayed in study
practices advising patients of the trial.
ED, emergency department; GP, general practitioner; TIA, transient ischaemic attack.
Table 5 Outcomes
Study
n/N (%) of patients with
suspected low-risk TIA
entering referral pathway
90-day stroke rate
n/N (%)
Unadjusted
OR (95% CI) p
Adjusted
HR (95% CI) p
Sanders et al54 301/488 (83) 7/468 (1.5) intervention
7/150 (4.67) control
3.78 (−0.19 to 9.89) 0.43l (0.12 to 1.59) 0.21)
Montassier et al53 62/118 (52) 1 (1.7) stroke
3 (5) TIA
Not reported Not reported
Griffiths et al55 Not reported 3/200 (1.5) Not reported Not reported
Lavallee et al52 808/1085 (74) Not reported Not reported Not reported
Rothwell et al6 281/644 (44) 6/281 (2.1) Not reported 020 (008 to 049); 00001
Ranta et al58 172/291 (59) 2/172 (1.2)
(intervention)
5/119 (4.2) (control)
0.27 (0.05 to 1.41)
0.098
Not possible to calculate
due to small number of
events
TIA, transient ischaemic attack.
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pathways. Our literature review did not reveal any path-
ways used by paramedics. There was limited comparative
evidence about effects of these pathways on patient out-
comes. Only one study used a randomised controlled
design and others were limited by not having a con-
trolled comparator group. Two of the included papers
were protocols and no results were reported for one of
these. Findings should be treated cautiously, although
the pathways did not appear to negatively affect patient
safety.
Strengths and limitations
We followed a systematic approach based on guidance
for carrying out a scoping review and reported our
methods fully in line with guidance.38 44
Two researchers had carried out the search and
screening stages. We did not undertake a full systematic
review since our objective was to inform intervention
development in our feasibility study and we were con-
cerned about timescales as experienced by other
authors.45 We therefore took a pragmatic decision to
balance thoroughness and transparency while delivering
timely scoping review results in order to inform develop-
ment of intervention and implementation of our trial.
We also discussed methods and ﬁndings within the study
team to assess and monitor processes.
We did not assess reporting quality of papers and
chose to include all study designs in order to search
widely across the research literature.38 41 However, all
papers were published in international peer-reviewed
journals and we have reported study results to aid inter-
pretation, in line with recommendations.38
Implications for practice and research
Suspected TIA is common; identiﬁcation and appropri-
ate referral may be an opportunity to prevent subse-
quent stroke.2–5 Timely access to specialist evaluation is
therefore important, particularly since two out of three
cases diagnosed in hospital can be missed and onward
referrals from hospital to specialist services are often
delayed.13 59
This review extends the ﬁndings of Ranta and
Barber60 by describing an additional four prehospital
pathways for patients with TIA. In this study, we have
identiﬁed features of referral pathways which safely
avoided the need for patients with low risk of further
TIA or stroke to be admitted to hospital. Physicians used
a decision tool to assess and triage patients—software,
algorithms or checklists—although stroke physicians also
had direct input to the pathway by contributing to triage
decisions, particularly within primary care. Using the
decision tool, physicians followed predeﬁned steps to
communicate patient details directly to a specialist or
central point where specialist review would be arranged.
Antiplatelet therapy was prescribed (usually aspirin)
unless contraindicated. These pathways were used by
family doctors and ED physicians but there is no evi-
dence of use by paramedics.
The decision tools ranged from a simple yes/no
checklist of ﬁve questions to a computer-based algorithm
incorporating real-time and historic data to offer referral
options. In New Zealand, Ranta et al58 reported that
electronic decision assistance systems reduced unneces-
sary ED and neurospecialist investigation. Meanwhile a
UK-tested hospital online system has stratiﬁed and
speedily referred patients with TIA for clinical assess-
ment with no patients receiving wrong risk scores.61
Our ﬁndings contribute evidence to support using a
risk assessment procedure to aid clinical assessment in
the prehospital environment with the potential to
extend pathways for patients experiencing less urgent
conditions to avoid hospital admission.18–27 Correct
diagnosis of TIA and assessment of risk of future events
is recognised to be challenging, since symptoms are
temporary and mimic other, often common, condi-
tions.12 14 However, several studies described using the
ABCD2 tool to assess risk of further TIA or stroke,
without reported difﬁculties. This suggests the tool can
be used to assess and triage patients presenting in the
community before onward referral. The Royal College
of Physicians identiﬁed that paramedics need to be able
to identify stroke and TIA cases and called for further
research to validate safe and appropriate care pathways
(p. 61)14 in the prehospital setting. Decision support
tools contribute evidence to enhance risk assessment
procedures and support clinical appraisal. Although
paramedics are risk averse and want a process to ‘cover
our backs’,62 computerised clinical decision support has
enabled them to refer twice as many patients to appro-
priate treatment in place of hospital conveyance, with
potential cost-savings. However, paramedics’ use of elec-
tronic processes is not widespread.20 Our ﬁndings show
that simple checklists, algorithms and computer-based
automatic population and calculation features of
computerised systems are all feasible and safe in the
prehospital setting.
The lack of evidence about paramedic referral path-
ways highlights the need for further research. The safety
and acceptability of referral pathways, to patients and to
providers and commissioners of healthcare, is not
known nor their effect on resource usage. We identiﬁed
three questions for immediate investigation, in order to
understand the feasibility, safety and effects of prehospi-
tal referral of patients with suspected TIA:
▸ Can paramedics safely identify patients with suspected
TIA and assess risk of further TIA or stroke?
▸ Do prehospital referral pathways enable patients to
see specialist clinicians in a timely way?
▸ How do prehospital referral pathways affect patients’
experience, treatment and outcomes?
CONCLUSION
The scoping method allowed us to identify and describe
existing knowledge about referral of patients with TIA to
avoid hospital admission. This has shown that there is
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limited evidence describing pathways delivered by family
doctors or emergency care physicians and none for para-
medics. The identiﬁed pathways used checklists to diag-
nose TIA and identify patients for onward transport or
admission to hospital or direct referral to a specialist
stroke clinic. Referral arrangements were communicated
by fax or telephone hotline and patients received
bespoke information and interim medication such as
aspirin before being left at home.
The absence of evidence about paramedic referral
pathways underlines the need for research into safe and
effective processes to optimise treatment of patients with
TIA and reduce the burden on hospitals and EDs. Our
research team includes paramedics, ambulance services
managers, nurses, stroke clinicians and patients along-
side experienced trialists. We have used ﬁndings from
this review alongside results from a survey of UK ambu-
lance services and clinical and operational expertise
from stroke, ED and prehospital practitioners, to
develop and test a referral pathway protocol for parame-
dics to use when responding to patients with suspected
TIA. We will investigate the feasibility of applying and
evaluating this pathway to assess whether it can be deliv-
ered by paramedics and is safe and acceptable for
patients, in order to plan a fully powered multicentre
randomised trial if indicated.
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